Empowering the oncology community to improve quality of care and patient outcomes through transformational data analytics.
Conquering Cancer Through Research, Education, and Promotion of the Highest Quality Patient Care
The mission of the American Society of Clinical Oncology (ASCO) drives its numerous initiatives, and CancerLinQ is one of our most ambitious. This program was created to give oncologists a robust quality monitoring system that collects and analyzes data from all patient encounters. But it also gives us the ability to learn from every one of them so that we can deliver to our patients the highest possible quality of care.
We continue to promote and provide for lifelong learning for oncology professionals, and we will always support cancer research. But CancerLinQ allows us to build on our global network of oncology expertise so that we can make a tangible difference in the lives of people with cancer.
CancerLinQ LLC is a subsidiary of the American Society of Clinical Oncology established for the development and operation of the CancerLinQ initiative. CancerLinQ is a health information technology platform aimed at enhancing and improving the understanding and treatment of cancer. The team is comprised of staff focused solely on CancerLinQ—a team dedicated to using big data to help conquer cancer. CancerLinQ LLC has two offices—the main office collocated with ASCO in Alexandria, VA and a second office in San Francisco, CA.
Shaping the future of cancer care through data-driven innovation.
CancerLinQ™ is a system that continually learns from itself and enables change:
- Tracks the quality of care in real time to ensure patients get all the care they need and none they don’t
- Gains insights from de-identified data on thousands of patients, potentially identifying important trends and increasing the confidence of care decisions
- Visualizes patients’ medical histories in powerful new ways
Shoppers have Amazon. Students have Google. Oncologists will have CancerLinQ.– CNN
Meet Our Leadership and Advisory Committees
Why We Care
Because the mission of CancerLinQ touches the lives of so many patients and their loved ones, if our effort can somehow reduce their pain, or prolong their time together with their loved ones, then our effort will be worthwhile. - Michael Zhao
CancerLinQ Is Well On Its Way
The Institute of Medicine releases
A Foundation for Evidence-Driven Practice: A Rapid Learning System for Cancer Care – Workshop Summary, which lays out the vision for a rapid learning system.
Prototype development begins
Aims to demonstrate the feasibility of CancerLinQ and obtain insights for the full system.
Prototype successfully completed
Includes more than 170,000 de-identified medical records of breast cancer patients from oncology practices around the United States and proves feasibility of main functionality.
Data Governance and Advisory Committees established
Leading thinkers from an array of relevant fields engaged to advise on design and implementation. Advisors include leading oncologists, patient advocates, privacy advocates, health outcomes researchers, ethicists, health IT experts, and many others.
Functional requirements defined
Key requirements of CancerLinQ established and a search for best-in-class technology and expertise begins.
Database surpasses one million patient records
As the number of participating practices continues to grow, the data from de-identified electronic medical records represents health information from more than one million people with cancer.